Publication
Midregional proatrial natriuretic peptide improves risk stratification after ischemic stroke.
Journal Paper/Review - Jan 10, 2018
De Marchis Gian Marco, Schneider Juliane, Weck Anja, Fluri Felix, Fladt Joachim, Foerch Christian, Müller-Stich Beat P, Luft Andreas R, Christ-Crain Mirjam, Arnold Marcel, Katan Mira
Units
PubMed
Doi
Contact
Citation
De Marchis G, Schneider J, Weck A, Fluri F, Fladt J, Foerch C, Müller-Stich B, Luft A, Christ-Crain M, Arnold M, Katan M. Midregional proatrial natriuretic peptide improves risk stratification after ischemic stroke. Neurology 2018; 90:e455-e465.
Type
Journal Paper/Review (English)
Journal
Neurology 2018; 90
Publication Date
Jan 10, 2018
Issn Electronic
1526-632X
Pages
e455-e465
Brief description/objective
To validate midregional proatrial natriuretic peptide (MR-proANP) for outcome prediction and diagnosis of cardioembolic stroke etiology compared to established clinical variables.